Arcus Biosciences, Inc. Earnings Dividend

Arcus Biosciences, Inc.’s revenue fell -74.38% since last year same period to $41Mn in the Q2 2026. On a quarterly growth basis, Arcus Biosciences, Inc. has generated 141.18% jump in its revenue since last 3-months.

Arcus Biosciences, Inc.’s net profit fell -1037.5% since last year same period to $-91Mn in the Q2 2026. On a quarterly growth basis, Arcus Biosciences, Inc. has generated 28.91% jump in its net profits since last 3-months.

Arcus Biosciences, Inc.’s net profit margin fell -4339.02% since last year same period to -221.95% in the Q2 2026. On a quarterly growth basis, Arcus Biosciences, Inc. has generated 70.52% jump in its net profit margins since last 3-months.

Arcus Biosciences, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.95 - a 3.06% jump from last quarter’s estimates.

Arcus Biosciences, Inc.’s earning per share (EPS) estimates for the current year stand at -0.95.

Arcus Biosciences, Inc.’s earning per share (EPS) fell -Inf% since last year same period to -0.72 in the Q2 2026. This indicates that the Arcus Biosciences, Inc. has generated -Inf% annual rate of fall in its earning per share (EPS) in the last 4 quarters.